22 Interstitial Lung Disease Clinical Trials in Chicago, IL (2026)

Q: How do I join a clinical trial in Chicago?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Chicago research site will contact you.

Recruiting Interstitial Lung Disease Studies in Chicago

NCT05382572Recruiting

Pulmonary Fibrosis Foundation Community Registry

Pulmonary fibrosis (PF) results from a diverse group of health conditions and affects the lives of patients (including those who are post lung transplant), caregivers and family members. The Pulmonary...

Chicago, IL10,000 participantsPulmonary Fibrosis Foundation

View Study Details

NCT00470327Recruiting

A Study of the Natural Progression of Interstitial Lung Disease (ILD)

We propose to acquire data and blood samples on all patients being cared for by the Interstitial Lung Disease (ILD) program. Additionally, we will collect data and blood samples from a control group f...

Chicago, IL4,000 participantsUniversity of Chicago

View Study Details

NCT07136610Recruiting

Standardized Application of Feeding Evaluations Using SMART Tool

Premature and medically complex infants have delayed development of oral feeding skills, leading to prolonged hospitalization, costs, and family stress. There is no "gold standard" infant feeding skil...

Chicago, IL3,500 participantsWake Forest University Health Sciences

View Study Details

NCT07220850Recruiting

Oral Health Intervention for Caregivers of Children Presenting for Dental Surgery

Too many young children, particularly those living in poverty, present for dental surgery under anesthesia - an expensive, potentially dangerous, short-term fix that often results in recurring oral he...

Chicago, IL420 participantsUniversity of Illinois at Chicago

View Study Details

NCT04571658Recruiting

NEPTUNE Match Study

NEPTUNE Match is an additional opportunity offered to NEPTUNE study participants to prospectively recruit and communicate patient-specific clinical trial matching with kidney patients and their physic...

Chicago, IL375 participantsUniversity of Michigan

View Study Details

NCT06883045Recruiting

A Novel mHealth Intervention to Improve Outcomes of Children With Medical Complexity

Children with medical complexity (CMC) are the most vulnerable of children with chronic diseases, who have complex, multisystem chronic diseases affecting ≥3 organ systems, severe functional limitatio...

Chicago, IL360 participantsUniversity of Utah

View Study Details

NCT05125822Recruiting

Adaptive Mechanisms Responsible for Weight Change in Youth With Obesity

In this study, doctors want to find out more about why people who lose weight often regain the weight that they have lost once they resume a regular diet and whether hormones might play a role in weig...

Chicago, IL260 participantsAnn & Robert H Lurie Children's Hospital of Chicago

View Study Details

NCT03819608Recruiting

Neuromodulation and Neurorehabilitation for mTBI

This study will determine (i) the magnitude of immediate and sustained effects of a current clinical standard interactive computer attention processing training (APT) when combined with intermittent t...

Chicago, IL200 participantsNorthwestern University

View Study Details

NCT06241300Recruiting

Executive Function and Parenting in Childhood

Deficits in executive functioning (EF) disproportionately impact children living in poverty and increase risk for psychopathology, particularly disruptive behavior disorders. This randomized clinical ...

Chicago, IL180 participantsUniversity of Illinois at Chicago

View Study Details

NCT04938349Recruiting

Dual Task Perturbation Training for OAwMCI

Studies have determined that compared to cognitively intact older adults (CIOA), older adults with mild cognitive impairment (OAwMCI) exhibit more pronounced balance and gait impairments which lead to...

Chicago, IL142 participantsUniversity of Illinois at Chicago

View Study Details

NCT05571059Recruiting

Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)

Ifetroban prevents and treats lung fibrosis due to multiple causes (bleomycin, genetic, radiation). The safety and efficacy of oral ifetroban will be assessed in patients with IPF....

Chicago, IL128 participantsCumberland Pharmaceuticals

View Study Details

NCT06672549Recruiting

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

The purpose of this pediatric, chronic weight management, Phase 3 Master Protocol (PWMP) is to create a framework to evaluate the safety and efficacy of pharmacologic agents for the treatment of obesi...

Chicago, IL125 participantsEli Lilly and Company

View Study Details

NCT05999994Recruiting

A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer

The main purpose of the master is to help the research sites and sponsor carry out several clinical trials more efficiently by providing a common research protocol. Individual clinical trials under th...

Chicago, IL105 participantsEli Lilly and Company

View Study Details

NCT00515567Recruiting

Explanted Lung Tissues With Pulmonary Fibrosis

The goal of this study is to use the tissues from the explanted lungs in order to better study the cause of pulmonary fibrosis at a cellular level....

Chicago, IL90 participantsUniversity of Chicago

View Study Details

NCT06820593Recruiting

Technology-Enhanced Asthma Care in Children at Clinic and Home Study

A randomized controlled trial with parent-child pairs of children with persistent or uncontrolled asthma. An intervention group (n=40 parent-child pairs) will receive the mobile health (mHealth) app a...

Chicago, IL80 participantsAnn & Robert H Lurie Children's Hospital of Chicago

View Study Details

NCT05667701Recruiting

Soy Isoflavones For Inner City Infants At Risk For Asthma (SIRA) Study

The goal of this clinical trial is to compare soy isoflavones to placebo in children who at risk of asthma and have a genetic variation which results in them making more of a pro-inflammatory protein,...

Chicago, IL65 participantsRajesh Kumar

View Study Details

NCT06894979Recruiting

Testing the Addition of an Anti-Cancer Drug, AZD1390, During Radiation Therapy for Newly Diagnosed High Grade Glioma, Diffuse Midline Glioma, or Diffuse Intrinsic Pontine Glioma

This phase I clinical trial studies the side effects and best dose of AZD1390 and to see how well it works when given together with radiation therapy for the treatment of pediatric patients with high ...

Chicago, IL54 participantsChildren's Oncology Group

View Study Details

NCT05805410Recruiting

Neuromuscular Mechanisms of Specific Trunk Interventions in Children With CP

Determine the effect of repeated pelvis perturbation training on trunk posture and locomotor function in children with CP....

Chicago, IL44 participantsShirley Ryan AbilityLab

View Study Details

NCT05879250Recruiting

WP1066 and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma

This phase II trial tests how well the combination of WP1066 and radiation therapy works in treating newly diagnosed glioblastoma. Glioblastoma is difficult to treat effectively because the cells with...

Chicago, IL39 participantsNorthwestern University

View Study Details

NCT06247787Recruiting

A Study to Find the Highest Dose of Imetelstat in Combination With Fludarabine and Cytarabine for Patients With AML, MDS or JMML That Has Come Back or Does Not Respond to Therapy

This phase I trial tests the safety, side effects, and best dose of imetelstat in combination with fludarabine and cytarabine in treating patients with acute myeloid leukemia (AML), myelodysplastic sy...

Chicago, IL36 participantsChildren's Oncology Group

View Study Details

NCT06410248Recruiting

Triapine in Combination With Temozolomide for the Treatment of Patients With Recurrent Glioblastoma

This phase I trial tests the safety, side effects, and best dose of triapine in combination with temozolomide in treating patients with glioblastoma that has come back after a period of improvement (r...

Chicago, IL30 participantsNorthwestern University

View Study Details

NCT06330844Recruiting

Race-Based Stress and Cognitive Training for MCI

This a two phase project that aims to pilot a new adaptation (Phase 1) of Motivationally Enhanced Compensatory Cognitive Training for Mild Cognitive Impairment (ME-CCT; an originally VA-based cognitiv...

Chicago, IL9 participantsRosalind Franklin University of Medicine and Science

View Study Details

About Interstitial Lung Disease Clinical Trials in Chicago

Interstitial lung disease is a group of disorders characterized by progressive scarring of lung tissue, leading to breathlessness and reduced oxygen exchange. Causes include autoimmune diseases, environmental exposures, and unknown factors. Treatment includes antifibrotic medications and immunosuppressants.

There are currently 22 interstitial lung disease clinical trials recruiting participants in Chicago, IL. These studies are seeking a combined 20,242 participants. Research is being sponsored by Pulmonary Fibrosis Foundation, University of Chicago, Wake Forest University Health Sciences and 11 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Interstitial Lung Disease Clinical Trials in Chicago — FAQ

Are there interstitial lung disease clinical trials in Chicago?

Yes, there are 22 interstitial lung disease clinical trials currently recruiting in Chicago, IL. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Chicago?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Chicago research site will contact you about next steps.

Are clinical trials in Chicago free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Chicago studies also compensate for your time and travel.

What interstitial lung disease treatments are being tested?

The 22 active trials in Chicago are testing new therapies including novel drugs, biologics, and treatment approaches for interstitial lung disease.

Data updated July 14, 2026 from ClinicalTrials.gov